The management of leukemias and lymphomas now includes the use of many targeted therapies. Nurses need to have an understanding of the targeted therapies and their side effects so they can appropriately manage the side effects that their patients with leukemias and lymphomas may experience.
• Precision Medicine in the Care of Patients With Leukemia/Lymphoma
• Expanded Treatment Options for Leukemia/Lymphoma

Many cancer patients experience cachexia. In collaboration with an interdisciplinary team including dietitians, oncology nurses are well positioned to implement proactive, multimodality interventions that improve clinical outcomes and quality of life for these patients.

Cancer-related fatigue (CRF) in older adults is amenable to resolution by nursing oversight that includes early assessment and the selection of appropriate management approaches. Oncology nurses working with older patient populations at high-risk for CRF should partner with rehabilitation colleagues to create and test exercise interventions that reduce the burden of this common symptom.

We still have much to do to fully understand the potential of complementary therapies as important elements in cancer treatment and health. Mind-body and body-based interventions may be able to improve health and prevent disease as effectively as pharmacologic agents—without the toxicities associated with pharmacologics, and as adjuncts to pharmacologic therapies they may help to maximize health and diminish disease with less toxicity.

Crizotinib is indicated for the treatment of patients with locally advanced or metastatic non–small-cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

As we ponder our future, it may also be timely not only to look at our personal lives but also to address our professional growth and maturation in a purposeful way.

News of note from the current literature.